PRODUCTS: The Medi-Jector VISION®

The Medi-Jector VISION® represents the seventh in a series of Medi-Jector devices, with each generation offering improvements over the previous versions. Antares pioneered the development of needle-free injection systems for individual use in 1979 and remains among the industry leaders as the technology continues to advance and is marketed worldwide.

click on image to view enlarged version

The Medi-Jector VISION® has been sold for use in more than 30 countries to deliver either insulin or human growth hormone. The product features a reusable, spring-based power source and disposable needle-free syringe, which eliminate the need for routine maintenance of the nozzle and allows for easy viewing of the medication dose prior to injection. The device’s primary advantage over earlier devices is its ease of use and cost efficiency. The product is also reusable, with each device designed to last for approximately 2000 injections (or approximately two years) while the needle-free syringe is disposable after approximately one week of continuous use.

Antares believes this method of administration is a particularly attractive alternative to the needle and syringe for the groups of patients described below.
 

Patient Candidates for Needle-Free Injection

• Young adults and children

• Patients looking for an alternative to needles

• Patients mixing insulins

• Patients unable to comply with a prescribed needle program

• Patients transitioning from oral medication to insulin

• New patients beginning an injection treatment program

The Medi-Jector VISION® administers injectable liquid pharmaceuticals by using a spring to push the solution or suspension through a micro-fine opening in the needle-free syringe. The opening is approximately half the diameter of a standard 30-gauge needle. A fine liquid stream is created which penetrates the skin, and the dose is dispersed into the layer of fatty, subcutaneous tissue. The injectable liquid pharmaceuticals are then absorbed into the bloodstream and distributed throughout the body, successfully producing the desired effect. The Medi-Jector VISION® is primarily used in Europe, Asia, Japan and elsewhere to provide a needle-free means of administering human growth hormone to patients with growth retardation and in the US to administer insulin to diabetic patients.

Click on this link to our Medi-Jector website www.medijector.com

click on image to view enlarged version

click on image to view enlarged version